Curis Inc. CRIS
Super Investor & Insider
1
Fondi che lo detengono
#1531
Rank consenso
1.4%
% dei portafogli
$6,194
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 0% | — | 49,554 | $6,194 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Curis Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers. The company's lead program centers on emavusertib (CA-4948), an orally available small molecule inhibitor targeting IRAK4 and FLT3, currently in clinical development for hematologic malignancies inclu…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees20
TickerCRIS
Statistics
Market Cap$19.9M
Revenue (TTM)$9.4M
Net Income-$7.6M
Net Margin-80.3%
EPS$-0.58
P/E-0.74
P/S2.35
P/B0.65
EV/EBITDA0.16
ROE-693.9%
Dividend Yield—
Price$0.50
Data: Twelve Data · Revenue = mcap / P/S